[Intermittent intravenous immunoglobulin infusion prevented relapses in patients with remission-exacerbation type chronic inflammatory demyelinating polyradiculoneuropathy].
Rinsho Shinkeigaku
; 46(3): 236-8, 2006 Mar.
Article
en Ja
| MEDLINE
| ID: mdl-16642939
ABSTRACT
The intravenous immunoglobulin infusion therapy (IVIg) has recently acquired an important role in the treatment of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). Some patients, however, require repetitive infusions to maintain the improvement. We planned a one-day therapy with 0.4 g/kg of IVIg in every 7 or 10 days for two CIDP patients who had required a 5-day course of IVIg in every month because of frequent exacerbations. Serum levels of IgG in both patients were kept as high as 2,000 mg/dl resulting in maintaining the improvement without any side effects.
Search on Google
Banco de datos:
MEDLINE
Asunto principal:
Inmunoglobulinas Intravenosas
/
Polirradiculoneuropatía Crónica Inflamatoria Desmielinizante
Límite:
Humans
/
Male
/
Middle aged
Idioma:
Ja
Año:
2006
Tipo del documento:
Article